Objective

Discovery Partnerships with Academia (DPAc) is a global GSK initiative that aims to establish integrated collaborations with academic groups to undertake early drug discovery and translate innovative research into medicines that benefit patients. The first collaborations were initiated in the UK before the initiative was expanded globally. Multiple projects are now up and running with academics in European and North American institutions, bringing together the deep biology and disease knowledge of academia with the drug discovery expertise of GSK to research and develop new medicines. These collaborations are focused from start to finish on delivery of a specific project with a joint team working together towards agreed common goals. This presentation will describe the DPAc model, highlighting examples of collaborations and initial learnings.